Using parasternal intercostal muscle thickening to help decide when to stop mechanical ventilation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Critically ill patients who have been mechanically ventilated for 24 hours or more and are undergoing their first spontaneous breathing trial will be enrolled at Cairo University. Participants will receive bedside ultrasound measurement of the parasternal intercostal thickening fraction, with one group having that measurement used as an added weaning criterion and a control group receiving a sham measurement. The study will compare reintubation rates after extubation and track ventilation duration and related complications. The interventional design tests whether the added muscle-based criterion improves decisions about liberation from mechanical ventilation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* critically ill patient mechanically ventilated for 24 hours or more first spontaneous breathing trial

Exclusion Criteria:

* patient refusal difficult ultrasound views tracheostomized patient neuromuscular disorders

Where it's running

• Cairo University
  Cairo, Giza Governorate, Egypt Recruiting

Study contacts

• Study coordinator: Cairo university
• Email: kasralainirec@gmail.com
• Phone: +201275716942

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transducer levelling errors in everyday ICU practice

  In critically ill, vasopressor-treated adults with arterial and central venous lines, this study tests how small height differences in pressure transducers may lead to measurement errors that could affect treatment decisions.

  Recruiting Vastra Gotaland Region · Gothenburg and 1 other locations · NCT07330505

• What predicts death in the ICU? Analyzing APACHE II in Colombian patients

  This study tests how well the APACHE II score predicts ICU mortality in adults treated at a Colombian hospital.

  Recruiting Hospital Departamental de Villavicencio · Villavicencio, Meta Department · NCT07249749

• Testing SGLT2 inhibitors for treating sepsis in adults

  This study is testing if a new type of diabetes medication can help adults with sepsis recover better and feel safer.

  Recruiting at 2 sites Hospital Authority, Hong Kong · Hong Kong, Hong Kong and 2 other locations · NCT06473844

• Analgesia Nociception Index monitoring of the autonomic nervous system during continuous renal replacement therapy

  We will try using the Analgesia Nociception Index to see if changes in autonomic signals match blood pressure and heart responses when fluid is removed during continuous renal replacement therapy in critically ill adults.

  Recruiting Hospices Civils de Lyon · Bron · NCT06285162

• Using remote ischemic preconditioning to prevent kidney injury in septic patients

  This study is testing if a special technique that temporarily restricts blood flow in the arm can help prevent kidney injury in critically ill patients with sepsis.

  Recruiting Universität Münster · Münster · NCT05830669

• Investigating infections in critically ill patients on continuous renal replacement therapy

  This study looks at critically ill patients on a special kidney treatment to see how often they get new infections and what might cause them.

  Recruiting at 5 sites University Hospital Muenster · Innsbruck and 4 other locations · NCT05450185

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.